A single dose of RSV vaccine is recommended for all adults aged ≥75 years. RSV hospitalisation rates increase with age, and people aged ≥75 years are likely to have the greatest benefit from vaccination.
RSV vaccine may be given at any time of the year but, where possible, should be offered before the start of the RSV season.
Either Abrysvo or Arexvy may be used, with no brand preference.
Protection lasts for at least 2 years, and the need for further doses has not been established.
